ArticleBioengineered2022

LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP).

Wen Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.